This article is for informational purposes only and does not constitute medical advice. The information contained herein is not a substitute for and should never be relied upon for professional medical advice. Always talk to your doctor about the risks and benefits of any treatment. Learn more about our editorial standards here.
Obesity is a disease characterized by having excessive body fat, increasing a person’s risk for many serious health problems, such as heart disease, diabetes, and even some cancers.
Diabetes is a condition that causes blood sugar levels to become higher than normal. This is due to problems with how the body makes or uses insulin, the hormone that manages blood sugar (glucose) levels.
Fatty liver disease is when fat builds up in your liver. It can lead to liver scarring, liver damage, and liver cancer. You might not experience any symptoms of fatty liver disease until it causes health issues.
Cardiovascular disease is a group of conditions that cause problems with your heart and blood vessels. According to the World Health Organization (WHO), cardiovascular diseases are the leading cause of death worldwide. They lead to a combined 17.9 million deaths per year.
Hypertension — aka high blood pressure — occurs when the heart generates too much pressure in the blood vessels. It affects half of American adults, but it often has no symptoms. Untreated hypertension can lead to stroke, heart attack, and heart disease, so it’s important to get your blood pressure checked regularly.
Insulin is a pancreatic hormone that allows the body to lower blood sugar levels (glucose) after eating. People with insulin resistance usually produce more insulin to offset their body’s insufficient response.
Ozempic® is FDA-approved for type 2 diabetes but sometimes prescribed off-label for weight loss.
To get Ozempic® online, you’ll complete a health assessment, have your info reviewed by a licensed provider, and (if prescribed) the medication will be delivered to your door.
Alternatives like Wegovy® and Zepbound® may be easier to access for weight loss.
If you’ve been trying to lose weight, you may wonder how to get an Ozempic® prescription — and whether you can get it online. Ozempic® (semaglutide) is approved by the Food and Drug Administration (FDA) for type 2 diabetes, but some healthcare providers prescribe it off-label for weight loss.
Let’s break down how to get Ozempic® for weight loss, how online prescribing works, and what alternatives and costs to expect.
If you’re trying to figure out how to get on Ozempic® and whether you qualify for it — either through your insurance plan or via an off-label prescription for weight loss — here are the basics, broken down into simple steps.
1. Know the FDA-Approved Criteria
Ozempic® is FDA-approved to improve blood sugar levels (glucose) in adults with type 2 diabetes and to reduce cardiovascular risk in people with type 2 diabetes and established heart disease. It’s not FDA-approved for weight loss.
2. Understand Off-Label Prescribing
Some healthcare providers may prescribe Ozempic® off-label for certain conditions, including weight loss or polycystic ovary syndrome (PCOS).
Off-label use means a medication is prescribed for something other than its FDA-approved purpose.
3. See If You Meet Wegovy® Guidelines
Wegovy is approved for obesity and overweight. FDA guidelines state that to be eligible for Wegovy®, you must:
Have a body mass index (BMI) of 30 or greater
Or have a BMI of at least 27 with at least one weight-related health condition, such as high blood pressure (hypertension), high cholesterol, heart disease, or sleep apnea
If you fall into either category, a provider may determine that semaglutide — possibly in the form of off-label Ozempic® — is appropriate.
4. Consider Alternatives
If you don’t have diabetes, you may still qualify for other GLP-1 (glucagon-like peptide-1) receptor agonist medications that are FDA-approved for weight loss. This includes Wegovy® (semaglutide) and Zepbound® (tirzepatide).
These medications might be easier to access for weight-related treatment than off-label Ozempic®. To figure out if an alternative treatment is a good fit, a healthcare provider will look at your:
If the provider deems it appropriate for your needs, you might be able to get an off-label prescription for Ozempic® for weight loss from a licensed healthcare professional, either online or in person.
How to Get Ozempic® Online
Getting Ozempic® online is generally a straightforward process. Most telehealth platforms follow a similar set of steps:
Choose a telehealth provider. Several online services — including Hers, Found, Ro, and Eden — connect patients with licensed healthcare professionals who can evaluate whether a GLP-1 medication is appropriate.
Complete a medical intake form. You’ll typically start by answering questions about your health history, symptoms, and body weight. This will help determine your BMI for eligibility. Some platforms may also request recent lab work.
Meet with a licensed provider. Depending on the service and your state, this may be through a video visit, audio call, or secure messaging. The provider will determine whether Ozempic® or another GLP-1 medication is clinically appropriate.
Receive your prescription, if eligible. If prescribed, your provider will send the medication to the pharmacy of your choice or coordinate home delivery through the platform’s partner pharmacies. Availability of brand-name Ozempic® may vary based on supply, insurance coverage, and state regulations.
Access follow-up care. Most platforms offer some form of ongoing support. Hers, for example, includes unlimited messaging with providers and access to lifestyle tools.
Not all platforms prescribe brand-name Ozempic®. Some offer alternatives like Wegovy®. Availability, pricing, and insurance options differ among telehealth services.
Compare telehealth providers and find out where to get Ozempic® online.
Health insurance is unlikely to cover the cost of Ozempic® if it’s prescribed for weight management because weight loss isn’t its FDA-approved indication.
Ozempic® can be expensive, especially without insurance coverage. The list price for one pen, which typically contains two to four doses, is close to $1,000.
It’s also important to factor in long-term costs. GLP-1 receptor agonists like Ozempic® are generally taken on an ongoing basis to maintain their effects, so monthly expenses can add up over the course of your weight loss journey.
Your final cost will depend on factors like insurance coverage, pharmacy pricing, dose, and whether your plan covers GLP-1 medications for your specific health needs.
The process of getting Ozempic® is the same whether insurance covers it or not. If you’re paying out of pocket, you’ll still need to consult a healthcare professional in person or through a telehealth platform to get a prescription.
When filling that prescription, you’ll pay for it outright at the pharmacy instead of having them bill your insurance. Or you’ll pay through the telehealth platform.
To get the best price, look into drug coupon codes and other cost-saving options.
Many GLP-1 agonist medications that work similarly to Ozempic® are now available to help with weight loss. There are also other medications that can be used for weight management, including weight loss pills.
Here’s a side-by-side look at some of the alternatives and how they work.
Medication
What It Is & How It Works
Form & Dosing
Wegovy® (semaglutide)
GLP-1
Higher dose of semaglutide than Ozempic®
FDA-approved for weight loss
Suppresses appetite and slows gastric emptying
Average 20% weight loss over 68 weeks in clinical trials
Once-weekly injection
Metformin
Diabetes medication
Sometimes used off-label for weight loss and PCOS
May increase natural GLP-1 and help regulate appetite
Hers offers access to a range of prescription weight loss treatments, including GLP-1 injections and weight loss pills. Through Hers, you can get Ozempic ® online if a provider determines the prescription drug is right for you.
Hers offers access to these weight loss injections for those who are eligible:
Ozempic®
Wegovy®
Generic liraglutide
With Hers, you get unlimited, 24/7 access to providers if you have questions or need dose adjustments. You also access the Hers app. The mobile app has:
Tools to track your progress, protein intake, hydration, and more
Can Ozempic® be prescribed for weight loss? Yes, Ozempic® can be prescribed off-label for weight loss, but eligibility depends on your BMI, health history, and a provider’s clinical judgment.
If you don’t qualify for Ozempic®, FDA-approved GLP-1s like Wegovy® and Zepbound® — along with several non-GLP-1 weight-loss medications — might be effective alternatives.
Whether you pursue treatment online or in person, a licensed healthcare provider can help you understand your options and choose the safest, most appropriate approach for your goals.
Get answers to frequently asked questions about how to get prescribed Ozempic®.
Who can prescribe Ozempic® for weight loss?
A licensed healthcare provider — including physicians, nurse practitioners, and physician assistants — can prescribe Ozempic® when clinically appropriate. For weight loss, providers may prescribe it off-label after reviewing your BMI, health history, and weight-related conditions. This can be done in person or through a telehealth platform.
What are the most common side effects of Ozempic®?
Common side effects of Ozempic®include nausea, vomiting, diarrhea, constipation, stomach pain, and heartburn. A Novo Nordisk study found that these gastrointestinal symptoms are usually mild to moderate and tend to improve over time as your body adjusts to the medication.
Who shouldn’t take Ozempic®?
Ozempic®may not be safe for people with certain medical conditions, including a history of pancreatitis, acute gallbladder disease, diabetic retinopathy, severe kidney problems, or a personal or family history of medullary thyroid carcinoma (MTC). You should also let your provider know if you’re pregnant, trying to conceive, or breastfeeding, as it’s generally not recommended in these cases.
Blundell J, et al (2017). Effects of once‐weekly semaglutide on appetite, energy intake, control of eating, food preference and body weight in subjects with obesity. https://pmc.ncbi.nlm.nih.gov/articles/PMC5573908/
Chao AM, et al. (2019). Alcohol intake and weight loss during an intensive lifestyle intervention for adults with overweight/obesity and diabetes. https://pmc.ncbi.nlm.nih.gov/articles/PMC6309276/
Chavda VP, et al. (2022). Tirzepatide, a new era of dual-targeted treatment for diabetes and obesity: a mini-review. https://pmc.ncbi.nlm.nih.gov/articles/PMC9268041/
Collins L, et al. (2023). Glucagon-like peptide-1 receptor agonists. https://www.ncbi.nlm.nih.gov/books/NBK551568/
Fariba KA, et al. (2024). Topiramate. https://www.ncbi.nlm.nih.gov/books/NBK554530/
Frías JP, et al. (2021). Tirzepatide versus semaglutide once weekly in patients with type 2 diabetes. https://www.nejm.org/doi/full/10.1056/nejmoa2107519
Mahapatra MK, et al. (2022). Semaglutide, a glucagon-like peptide-1 receptor agonist with cardiovascular benefits for management of type 2 diabetes. https://pmc.ncbi.nlm.nih.gov/articles/PMC8736331/
NovoCare. (n.d.). Find out the cost for Ozempic. https://www.novocare.com/diabetes/products/ozempic/explaining-list-price.html
NovoCare. (n.d.). What is the list price for Wegovy® and will it impact me?. https://www.novocare.com/obesity/products/wegovy/let-us-help/explaining-list-price.html
Ozempic. (n.d.). What is Ozempic?. https://www.ozempic.com/important-safety-information.html
Ozempic (semaglutide) injection, for subcutaneous use. (2017). https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/209637lbl.pdf
Sherman MM, et al. (2016). Naltrexone/bupropion ER (Contrave). https://pmc.ncbi.nlm.nih.gov/articles/PMC4771085/
U.S. Food and Drug Administration (FDA). (2021). FDA approves new drug treatment for chornic weight management, first since 2014. https://www.fda.gov/news-events/press-announcements/fda-approves-new-drug-treatment-chronic-weight-management-first-2014
U.S. Food and Drug Administration (FDA). (2024). FDA approves first treatment to reduce risk of serious heart problems specifically in adults with obesity or overweight. https://www.fda.gov/news-events/press-announcements/fda-approves-first-treatment-reduce-risk-serious-heart-problems-specifically-adults-obesity-or
Wegovy® (semaglutide) injection, for subcutaneous use. (2023). https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/215256s007lbl.pdf
Wilding JPH, et al. (2022). Weight regain and cardiometabolic effects after withdrawal of semaglutide: the STEP 1 trial extension. https://dom-pubs.pericles-prod.literatumonline.com/doi/10.1111/dom.14725
Wilding J, et al. (2021). Once-weekly semaglutide in adults with overweight or obesity. https://www.nejm.org/doi/full/10.1056/NEJMoa2032183
Editorial Standards
Hims & Hers has strict sourcing guidelines to ensure our content is accurate and current. We rely on peer-reviewed studies, academic research institutions, and medical associations. We strive to use primary sources and refrain from using tertiary references. See a mistake? Let us know at blog@forhims.com!
Obesity
Diabetes
Fatty Liver Disease
Cardiovascular Disease
Hypertension
Insulin Resistance